Form D · Venture Capital Fund

Aditum Bio Fund 1, L.P.

Oakland, CA · CIK 0001782206

Offering snapshot reported Oct 23, 2020 · SEC filing

Reported sold: $133M
Investors reported: 26
Minimum accepted: $0
First sale: Jul 19, 2019

What changed?

Latest filing versus its linked predecessor, where available.

Reported investors0 → 26

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Oct 23, 2020	Amendment	$133,040,000	No comparison	26	SEC filing
Jul 17, 2019	Initial	Yet to sell	No comparison	0	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.7
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-344544

Source: Form D, filed Oct 23, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

ADITUM BIO FUND 1, L.P.

Investment adviser: ADITUM BIO MANAGEMENT COMPANY, LLC

Gross asset value: $179M
Beneficial owners: 228
ADV minimum commitment: $100K

Reported in Form ADV on Mar 31, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator REDBRICK ASSOCIATES, LLC SAN MATEO, California, United States Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor SENSIBA LLP SAN JOSE, California, United States

Custodian FIRST CITIZENS BANK & TRUST COMPANY SAN FRANCISCO, California, United States Related to adviser: No

Custodian WELLS FARGO BANK, NATIONAL ASSOCIATION SAN FRANCISCO, California, United States Related to adviser: No

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

SENSIBA LLP
PCAOB 854

FIRST CITIZENS BANK & TRUST COMPANY
LEI L9VVX1KT5TFTKS0MLF66

WELLS FARGO BANK, NATIONAL ASSOCIATION
LEI KB1H1DSPRFMYMCUFXT

Filing source

Form ADV 2066658 · Mar 31, 2026 · Schedule D 7.B.(1), fund 805-2910604912

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

Related funds

Funds whose names form a numbered series with this one and that share its city or the name of a related person. Form D does not state how these funds are related.

Fund	Latest Form D	Reported sold	Investors
Aditum Bio Fund 1, L.P. (this fund)	Oct 23, 2020	$133,040,000	26
Aditum Bio Fund 2, L.P.	Jul 14, 2021	Yet to sell	Not reported
Aditum Bio Fund 3, L.P.	May 31, 2024	Yet to sell	0

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
N/A Aditum Bio Gp 1, Llc	Director
Mark Fishman	Director
Joseph Jimenez	Director
Paul Sekhri	Director
N/A Trial Spark, Inc.	Director

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

1111 Broadway, Suite 1300
Oakland, CA, 94607